Loading clinical trials...
Loading clinical trials...
A Phase 4 Study to Assess the Safety and Immunogenicity of VAXCHORA (Cholera Vaccine, Live, Oral) in Children 2 to <18 Years of Age
Conditions
Interventions
VAXCHORA (Cholera Vaccine, Live, Oral)
Placebo
Locations
10
United States
Emory University
Atlanta, Georgia, United States
Johnson County Clin-Trials, Inc.
Lenexa, Kansas, United States
Heartland Research Associates, LLC
Wichita, Kansas, United States
University of Kentucky
Lexington, Kentucky, United States
Boston Medical Center
Boston, Massachusetts, United States
The Center for Pharmaceutical Research
Kansas City, Missouri, United States
Start Date
July 21, 2017
Primary Completion Date
September 10, 2019
Completion Date
March 6, 2020
Last Updated
June 28, 2023
Lead Sponsor
Bavarian Nordic
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions